搜尋結果
Alzheimer’s Drug Leqembi Sees Sales Pickup, Boosting Biogen Stock
The Wall Street Journal· 12 小時前Biogen said Wednesday that the number of patients taking the drug, Leqembi, has increased ...
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 12 小時前Health care, long an ailing stock market sector, has recovered over the past six months, with ...
Pharma Startup Uses AI to Test Old Drugs to Treat Rare Diseases
Bloomberg· 13 小時前Transcripta Bio’s AI software analyzes rare diseases to see if existing pharmaceuticals can ...
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump
Reuters· 14 小時前, opens new tab beat Wall Street estimates for first-quarter profit on Wednesday, helped by a ...
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
CNBC· 14 小時前... Leqembi became the first drug found to slow the progression of Alzheimer's disease ... ...
Who is Taylor Swift’s personal trainer and Dogpound founder Kirk Myers?
South China Morning Post· 14 小時前The Tortured Poets Department singer may be the star of her Eras Tour, but the production takes ...
... million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease ...
CNBC· 15 小時前More than 3 million people with Medicare could be eligible for coverage of Wegovy now that the blockbuster weight loss drug ...
Wegovy Access Expands to Millions in US on Medicare, Study Finds
Bloomberg· 15 小時前Have a confidential tip for our reporters? Medicare’s recent decision to cover Novo Nordisk ...
China's health literacy reaches 29.7 percent in 2023
China Daily· 17 小時前China's health literacy has steadily risen and reached 29.7 percent in 2023, up 1.92 percentage points from the previous ...
LCQ4: Manpower of dentists
HKSAR Government Press Releases· 17 小時前Following is a question by the Hon Michael Tien and a written reply by the Secretary for Health, Professor Lo Chung-mau, ...